Literature DB >> 2644985

Combinations of recombinant colony-stimulating factors are required for optimal hematopoietic differentiation in serum-deprived culture.

C A Sieff1, S C Ekern, D G Nathan, J W Anderson.   

Abstract

Previous in vitro investigations on enriched human hematopoietic progenitors have led to the conclusion that the purified recombinant multipoietins, interleukin 3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) can alone induce the formation of colonies from a variety of multipotent and lineage committed progenitors. Since fetal calf serum was included in these cultures and itself might contain growth factors or other cofactors, we re-examined the actions of the CSFs in serum-deprived conditions. Results show that both the multipoietins are inadequate stimuli of colony formation. At maximal concentrations IL-3 alone induces only 25% of the granulocyte and macrophage colony-forming units (CFU-G and CFU-M) produced by a T-cell conditioned medium that contains a mixture of CSFs. When IL-3 was added at the initiation of the cultures and erythropoietin (ep), G-CSF, or M-CSF added on day 3, almost full recovery of erythroid, granulocytic, and monocytic colonies, respectively, was obtained. Similar results were obtained with GM-CSF except that fewer erythroid colonies were recovered at high concentrations, and almost maximal CFU-M proliferation could be induced. These results show that in serum-deprived conditions, the multipoietins must be combined with lineage specific CSFs for full progenitor expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2644985

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  The Jeremiah Metzger lecture. Regulation of hematopoiesis.

Authors:  D G Nathan
Journal:  Trans Am Clin Climatol Assoc       Date:  1990

2.  Interleukin 6 is a permissive factor for monocytic colony formation by human hematopoietic progenitor cells.

Authors:  J H Jansen; J C Kluin-Nelemans; J Van Damme; G J Wientjens; R Willemze; W E Fibbe
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

3.  Differential myelopoietic responsiveness of BALB/c (Itys) and C.D2 (Ityr) mice to lipopolysaccharide administration and Salmonella typhimurium infection.

Authors:  V M Peterson; G S Madonna; S N Vogel
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

4.  Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates.

Authors:  A P Gillio; C Gasparetto; J Laver; M Abboud; M A Bonilla; M B Garnick; R J O'Reilly
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

5.  Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor.

Authors:  G A Blobel; C A Sieff; S H Orkin
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

6.  A human interleukin 3 analog with increased biological and binding activities.

Authors:  A F Lopez; M F Shannon; S Barry; J A Phillips; B Cambareri; M Dottore; P Simmons; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

7.  Colony growth of human hematopoietic progenitor cells in the absence of serum is supported by a proteinase inhibitor identified as antileukoproteinase.

Authors:  H M Goselink; J van Damme; P S Hiemstra; A Wuyts; J Stolk; W E Fibbe; R Willemze; J H Falkenburg
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.